Stentys Inc. (Stentys), a provider of interventional cardiologists solutions, has appointed Paul Geudens as vice president of sales & marketing, effective August 28, 2009. For the past 11 years, Geudens worked for Cordis Corp. (Johnson & Johnson). In his most recent endevour, Geudens employed as director of marketing, peripheral and neurovascular products, where he led new product launches across the franchise.
“Paul knows the cath lab market as well as anyone,” said Gonzague Issenmann, Stentys’ co-founder and chief executive officer. “He was the head of the interventional cardiology department at University Hospital Antwerp at the start of his professional career, and combined with his extensive business experience over more than two decades, Paul is an outstanding addition to our management team.”
“Paul joins Stentys on the heels of the Company’s CE Mark approval for its disconnectable and self-expanding platform, and he will lead Stentys’ commercial development in this $2.5 billion market,” added Jacques Séguin, M.D., Ph.D., co-founder and Chairman of Stentys and founder of CoreValve.